Daewon Pharmaceutical Co., Ltd. (KRX:003220)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,300
+70 (0.68%)
At close: Apr 10, 2026
Market Cap219.26B -27.4%
Revenue (ttm)605.43B +1.2%
Net Income-1.38B
EPS-87.38
Shares Out21.43M
PE Ration/a
Forward PE28.82
Dividend300.00 (2.93%)
Ex-Dividend DateDec 29, 2025
Volume40,960
Average Volume26,133
Open10,230
Previous Close10,230
Day's Range10,090 - 10,310
52-Week Range9,670 - 14,700
Beta0.26
RSI43.23
Earnings DateMay 15, 2026

About Daewon Pharmaceutical

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company’s principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a t... [Read more]

Sector Healthcare
Founded 1958
Employees 1,283
Stock Exchange Korea Stock Exchange
Ticker Symbol 003220
Full Company Profile

Financial Performance

Financial Statements